×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PALI – palisade bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PALI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/17
10:27 am
pali
Wolfe Highlights Differentiation Potential in Palisade Bio, Inc. (PALI) Clinical Profile [Yahoo! Finance]
Low
Report
Wolfe Highlights Differentiation Potential in Palisade Bio, Inc. (PALI) Clinical Profile [Yahoo! Finance]
4/16
08:50 am
pali
Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026
Low
Report
Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026
4/10
06:09 am
pali
Palisade Bio (PALI) was upgraded by Wolfe Research to "strong-buy".
Medium
Report
Palisade Bio (PALI) was upgraded by Wolfe Research to "strong-buy".
4/9
09:00 am
pali
Palisade Bio (PALI) is now covered by Wolfe Research. They set an "outperform" rating and a $7.00 price target on the stock.
Low
Report
Palisade Bio (PALI) is now covered by Wolfe Research. They set an "outperform" rating and a $7.00 price target on the stock.
4/8
09:00 am
pali
Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference
Medium
Report
Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference
3/31
02:57 pm
pali
Palisade Bio Shares Phase 1b PALI-2108 Data Showing Safety, PK and Early Crohn's Efficacy Signals [Yahoo! Finance]
Medium
Report
Palisade Bio Shares Phase 1b PALI-2108 Data Showing Safety, PK and Early Crohn's Efficacy Signals [Yahoo! Finance]
3/30
04:01 pm
pali
Palisade Bio Reports Positive Topline Data from Phase 1b Clinical Study of PALI-2108 in Fibrostenotic Crohn’s Disease
Medium
Report
Palisade Bio Reports Positive Topline Data from Phase 1b Clinical Study of PALI-2108 in Fibrostenotic Crohn’s Disease
3/26
08:53 am
pali
Palisade Bio (PALI) is now covered by HC Wainwright. They set a "buy" rating and a $7.00 price target on the stock.
Low
Report
Palisade Bio (PALI) is now covered by HC Wainwright. They set a "buy" rating and a $7.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/17
04:31 pm
pali
Form PRE 14A PALISADE BIO, INC. For: Apr 17
Low
Report
Form PRE 14A PALISADE BIO, INC. For: Apr 17
4/2
08:35 am
pali
Form 8-K PALISADE BIO, INC. For: Mar 27
Low
Report
Form 8-K PALISADE BIO, INC. For: Mar 27
3/20
04:23 pm
pali
Form 10-K PALISADE BIO, INC. For: Dec 31
Low
Report
Form 10-K PALISADE BIO, INC. For: Dec 31
2/17
04:41 pm
pali
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
2/17
04:29 pm
pali
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Point72 Asset Management, L.P.
Low
Report
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Point72 Asset Management, L.P.
2/17
04:00 pm
pali
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: PERCEPTIVE ADVISORS LLC
Low
Report
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: PERCEPTIVE ADVISORS LLC
2/17
12:09 pm
pali
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Squadron Capital Management LLC
Low
Report
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Squadron Capital Management LLC
2/13
08:10 pm
pali
Form 4 PALISADE BIO, INC. For: Feb 11 Filed by: Jones Mitchell Lawrence
Low
Report
Form 4 PALISADE BIO, INC. For: Feb 11 Filed by: Jones Mitchell Lawrence
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: